Institute for Clinical and Translational Research, Biomedical Research Center, Slovak Academy of Sciences, Dúbravská cesta 9, 84505, Bratislava, Slovakia.
Slovak Medical University in Bratislava, Limbová 12, 83303, Bratislava, Slovakia.
Cell Mol Neurobiol. 2018 Jan;38(1):363-370. doi: 10.1007/s10571-017-0511-3. Epub 2017 Jun 21.
Autonomic dysfunction is commonly detected in patients with multiple sclerosis (MS). However, data evaluating autonomic nervous system function in early MS are limited. Present study investigates response to two different stressors in newly diagnosed MS patients, looking for the signs of autonomic dysfunction at the beginning of the disease. We examined 19 MS patients and 19 age, sex, and body mass index matched healthy controls. MS patients were newly diagnosed, untreated, and with low expanded disability status scale (EDSS) values [median 1.0 (interquartile range 1.0-1.5)]. Two stressors were used to evaluate the response of autonomic nervous system: Stroop word-color interference mental stress test and orthostasis. Plasma levels of epinephrine and norepinephrine, blood pressure (BP), and heart rate variability (HRV) parameters were evaluated. At the end of Stroop test MS patients had lower systolic BP (121 ± 15 vs. 132 ± 17 mmHg, p = 0.044), lower heart rate (79 ± 9 vs. 88 ± 16 1/min, p = 0.041), and lower epinephrine increment (10 ± 22 vs. 30 ± 38 pg/ml; p = 0.049) compared to healthy controls. Norepinephrine response was unaffected in MS, however, with lower norepinephrine levels during the test (p = 0.036). HRV parameters were similar in both groups. No differences in BP, heart rate, catecholamines, and HRV parameters between groups during orthostatic testing were found. We found slightly diminished sympathetic response to mental stress test, but unchanged response to orthostasis, in newly diagnosed untreated MS patients. The results suggest that autonomic dysfunction in MS is connected with more developed disease.
自主神经功能障碍在多发性硬化症(MS)患者中很常见。然而,评估早期 MS 患者自主神经系统功能的数据有限。本研究调查了新诊断的 MS 患者对两种不同应激源的反应,以期在疾病早期发现自主神经功能障碍的迹象。我们检查了 19 名 MS 患者和 19 名年龄、性别和体重指数匹配的健康对照者。MS 患者为新诊断、未治疗且扩展残疾状况量表(EDSS)值较低[中位数 1.0(四分位距 1.0-1.5)]。使用两种应激源评估自主神经系统的反应:Stroop 字色干扰心理应激测试和直立位。评估了肾上腺素和去甲肾上腺素的血浆水平、血压(BP)和心率变异性(HRV)参数。在 Stroop 测试结束时,MS 患者的收缩压(121±15 对 132±17mmHg,p=0.044)、心率(79±9 对 88±161/min,p=0.041)和肾上腺素增加量(10±22 对 30±38pg/ml;p=0.049)均低于健康对照组。MS 患者的去甲肾上腺素反应不受影响,但在测试过程中去甲肾上腺素水平较低(p=0.036)。两组的 HRV 参数相似。在直立位测试中,两组之间的 BP、心率、儿茶酚胺和 HRV 参数无差异。我们发现新诊断未治疗的 MS 患者对心理应激测试的交感神经反应略有减弱,但对直立位的反应不变。结果表明,MS 中的自主神经功能障碍与疾病的发展有关。